USPTO serial 79227990
MODIFA
Reviewed by CopyMark Law Group
Reg. 5705840Status 709
- Filing date
- Status date
- Registration date
- Mar 26, 2019
- Examiner
- WHITE, RICHARD F
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MODIFA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna J. Bunton
Donna J. Bunton NIXON & VANDERHYE P.C.901 North Glebe Road, 11th FloorArlington, VA 22203UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and pharmaceutical preparations in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; medical drugs for human use for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; dietetic and nutritional preparations and substances in the form of foods and beverages adapted for medical use; diagnostic preparations for medical use; protein pharmaceuticals in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; protein arrays for medical diagnosis purposes; modified chemical compounds for medical purposes, namely, for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; modified protein arrays for medical diagnosis purposes | SECTION 71 - CANCELLED | — |
| 042 | Research and development of pharmaceuticals, protein pharmaceuticals, biological pharmaceuticals, proteins, protein structures, chemical modification of substances, compounds for efficient effect of drugs, compounds for controlled release of pharmaceutical substances within the pharmaceutical field | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Swedish Orphan Biovitrum AB (publ)
- Other trademarks owned by Swedish Orphan Biovitrum AB (publ)
- Other trademarks owned by Swedish Orphan Biovitrum AB (publ)
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MODIFA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 10, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 10, 2025 | C71T | CANCELLED SECTION 71 | — |
| Mar 26, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 20, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 16, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 26, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 26, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 26, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 26, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 8, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 8, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 15, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 15, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 9, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 9, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 27, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 10, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 10, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 3, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 2, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 10, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 6, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 1, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |